The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARCA BIOPHARMA INC | COM | 00211Y506 | 1,201,781 | 706,930 | SH | SOLE | 0 | 0 | 706,930 | ||
ABERCROMBIE & FITCH CO | CL A | 002896207 | 3,033,000 | 900 | SH | SOLE | 0 | 0 | 900 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 685,762 | 653,107 | SH | SOLE | 0 | 0 | 653,107 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 3,428,441 | 4,554,252 | SH | SOLE | 0 | 0 | 4,554,252 | ||
ASTROTECH CORP | COM | 046484309 | 1,871,281 | 220,410 | SH | SOLE | 0 | 0 | 220,410 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 16,659,341 | 5,462,079 | SH | SOLE | 0 | 0 | 5,462,079 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 3,534,100 | 1,454,362 | SH | SOLE | 0 | 0 | 1,454,362 | ||
AVROBIO INC | COM | 05455M100 | 5,442,213 | 4,001,627 | SH | SOLE | 0 | 0 | 4,001,627 | ||
BUILD-A-BEAR WORKSHOP INC | COM | 120076104 | 401,250 | 1,000 | SH | SOLE | 0 | 0 | 1,000 | ||
LISATA THERAPEUTICS INC | COM | 128058302 | 736,660 | 269,839 | SH | SOLE | 0 | 0 | 269,839 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 2,432,497 | 2,061,438 | SH | SOLE | 0 | 0 | 2,061,438 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 9,880,024 | 3,250,008 | SH | SOLE | 0 | 0 | 3,250,008 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 2,728,117 | 1,029,478 | SH | SOLE | 0 | 0 | 1,029,478 | ||
ELIEM THERAPEUTICS INC | COM | 28658R106 | 5,886,000 | 2,180,000 | SH | SOLE | 0 | 0 | 2,180,000 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 692,000 | 50,000 | SH | SOLE | 0 | 0 | 50,000 | ||
FORTE BIOSCIENCES INC | COM | 34962G109 | 1,447,591 | 1,761,702 | SH | SOLE | 0 | 0 | 1,761,702 | ||
GRAPHITE BIO INC | COM | 38870X104 | 1,126,842 | 445,391 | SH | SOLE | 0 | 0 | 445,391 | ||
CALCIMEDICA INC | COM NEW | 38942Q202 | 415,913 | 145,424 | SH | SOLE | 0 | 0 | 145,424 | ||
HOMOLOGY MEDICINES INC | COM | 438083107 | 454,850 | 748,108 | SH | SOLE | 0 | 0 | 748,108 | ||
INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 661,200 | 300 | SH | SOLE | 0 | 0 | 300 | ||
ISHARES TR | 0-3 MNTH TREASRY | 46436E718 | 27,072,900 | 270,000 | SH | SOLE | 0 | 0 | 270,000 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 312,550 | 446,874 | SH | SOLE | 0 | 0 | 446,874 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 738,728 | 442,352 | SH | SOLE | 0 | 0 | 442,352 | ||
NEUROGENE INC | COM | 64135M105 | 478,027 | 24,666 | SH | SOLE | 0 | 0 | 24,666 | ||
NEXTCURE INC | COM | 65343E108 | 349,370 | 306,465 | SH | SOLE | 0 | 0 | 306,465 | ||
ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | 2,914,201 | 1,261,559 | SH | SOLE | 0 | 0 | 1,261,559 | ||
RAIN ONCOLOGY INC | COM | 75082Q105 | 1,618,808 | 1,349,007 | SH | SOLE | 0 | 0 | 1,349,007 | ||
RENEO PHARMACEUTICALS INC | COM | 75974E103 | 2,102,766 | 1,314,229 | SH | SOLE | 0 | 0 | 1,314,229 | ||
SPDR SER TR | BLOOMBERG 1-3 MO | 78468R663 | 18,278,000 | 200,000 | SH | SOLE | 0 | 0 | 200,000 | ||
TALIS BIOMEDICAL CORP | COM NEW | 87424L207 | 318,435 | 42,743 | SH | SOLE | 0 | 0 | 42,743 | ||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 4,488,689 | 1,108,317 | SH | SOLE | 0 | 0 | 1,108,317 | ||
TOURMALINE BIO INC | COM | 89157D105 | 6,427,190 | 245,500 | SH | SOLE | 0 | 0 | 245,500 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 1,317,600 | 180,000 | SH | SOLE | 0 | 0 | 180,000 | ||
VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 771,000 | 150,000 | SH | SOLE | 0 | 0 | 150,000 | ||
WINGSTOP INC | COM | 974155103 | 1,210,500 | 900 | SH | SOLE | 0 | 0 | 900 |